Purchase Order 75N91021P00315

<p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for scientific equipment with a ceiling value of $22,682.10, effective June 19, 2020. The order, which is firm fixed-price with no small business set-aside, calls for equipment to be delivered to Denville, New Jersey, where the awardee is headquartered. Ultimate completion was scheduled for June 18, 2021.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Diagenode, LLC for scientific equipment. Under the firm fixed price contract, Diagenode will provide the specified equipment to support the National Cancer Institute's research efforts. The place of performance is Diagenode's facility in Denville, New Jersey. The contract period runs from September 22, 2023 through December 26, 2023. No subcontractors or set...

The National Institute on Aging issued a purchase order to Diagenode, LLC on January 27, 2020, with a ceiling value of $23,308.50 for firm fixed-price commercial items. Performance is scheduled to conclude by April 6, 2020, and will be executed in Denville, New Jersey, where the awardee is headquartered. The order procures specialized laboratory instrumentation and epigenetics research services, including DNA analysis tools and associated genomic methodologies aligned with the institute's...

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Diagenode, LLC for $4,750.00 on August 16, 2017, for parts replacement, calibration, and service repair of a Bioruptor instrument used for DNA and chromatin shearing. Place of performance is Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 15, 2017. No small business set-aside was used.</p>

<p>The National Cancer Institute issued a purchase order to Qiagen, LLC on December 18, 2020, for scientific equipment valued at $24,984.12, with completion required by January 31, 2021. Performance takes place in Germantown, Maryland. The order is priced on a firm fixed price basis.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Diagenode, LLC for $24,812.50 on September 6, 2018, for immunology proteomics research. The order carries no small business set-aside. Work is performed in Denville, New Jersey, with an ultimate completion date of October 5, 2018. The contract is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Qiagen, LLC for $24,480.00 on March 30, 2020, with performance completion by March 31, 2021. Work is performed in Bethesda, Maryland. This firm fixed-price purchase order acquired molecular diagnostics products or services—specific scope details are not provided in the award documentation.</p>

<p>The National Cancer Institute issued a $26,365.32 delivery order to Roche Diagnostics Corporation on April 14, 2016, for in vitro diagnostic products and laboratory instruments.</p> <p>Place of performance is Bethesda, MD. The order was firm fixed price with no set-aside designation and an ultimate completion date of April 14, 2016.</p>